140 related articles for article (PubMed ID: 679504)
1. Bromocriptine treatment of males with pituitary tumours, hyperprolactinaemia, and hypogonadism.
Nagulesparen M; Ang V; Jenkins JS
Clin Endocrinol (Oxf); 1978 Jul; 9(1):73-9. PubMed ID: 679504
[TBL] [Abstract][Full Text] [Related]
2. Bromocriptine in the treatment of the hyperprolactinaemia-hypogonadism syndromes.
Besser GM; Thorner MO
Postgrad Med J; 1976; 52suppl 1():64-70. PubMed ID: 959127
[No Abstract] [Full Text] [Related]
3. Hyperprolactinaemia in males: a heterogeneous disorder.
Walsh JP; Pullan PT
Aust N Z J Med; 1997 Aug; 27(4):385-90. PubMed ID: 9448878
[TBL] [Abstract][Full Text] [Related]
4. Hyperprolactinaemia in men-response to bromocriptine therapy.
Prescott RW; Johnston DG; Kendall-Taylor P; Crombie A; Hall K; McGregor A; Hall R
Lancet; 1982 Jan; 1(8266):245-8. PubMed ID: 6120274
[TBL] [Abstract][Full Text] [Related]
5. Hypogonadism, galactorrhoea and hyper-prolactinaemia: Evaluation of pituitary gonadotrophins reserve before and under bromocriptine.
Asfour M; L'Hermite M; Hedouin-Quincampoix M; Fossati P
Acta Endocrinol (Copenh); 1977 Apr; 84(4):738-49. PubMed ID: 322432
[TBL] [Abstract][Full Text] [Related]
6. Rapid regression of pituitary tumours during bromocriptine treatment of women with hyperprolactinaemia.
Bergh T; Nillius SJ; Lundberg PO; Moström U; Enoksson P; Ohman L; Wide L
Ups J Med Sci; 1982; 87(3):259-67. PubMed ID: 7157557
[TBL] [Abstract][Full Text] [Related]
7. Altered pulsatile secretion of luteinizing hormone in hypogonadal men with hyperprolactinaemia.
Winters SJ; Troen P
Clin Endocrinol (Oxf); 1984 Sep; 21(3):257-63. PubMed ID: 6434210
[TBL] [Abstract][Full Text] [Related]
8. Treatment of amenorrhoea, galactorrhoea and hypogonadism with bromocriptine.
Donald RA; Espiner EA; Livesey JH
Aust N Z J Med; 1978 Jun; 8(3):262-6. PubMed ID: 279321
[TBL] [Abstract][Full Text] [Related]
9. Bromocriptine treatment of hyperprolactinaemic hypogonadism.
Thorner MO; Besser GM
Acta Endocrinol Suppl (Copenh); 1978; 216():131-46. PubMed ID: 347858
[TBL] [Abstract][Full Text] [Related]
10. Hyperprolactinaemia and hypogonadism in men: response to exogenous gonadotrophins.
Luboshitzky R; Rosen E; Trestian S; Spitz IM
Clin Endocrinol (Oxf); 1979; 11(2):217-23. PubMed ID: 487619
[TBL] [Abstract][Full Text] [Related]
11. Bromocriptine treatment of prolactin-secreting pituitary adenomas may restore pituitary function.
Warfield A; Finkel DM; Schatz NJ; Savino PJ; Snyder PJ
Ann Intern Med; 1984 Dec; 101(6):783-5. PubMed ID: 6497193
[TBL] [Abstract][Full Text] [Related]
12. Hypogonadism, hyperprolactinaemia, and temporal lobe epilepsy in hyposexual men.
Spark RF; Wills CA; Royal H
Lancet; 1984 Feb; 1(8374):413-7. PubMed ID: 6142149
[TBL] [Abstract][Full Text] [Related]
13. Effect of bromocriptine on DNA synthesis, growth and hormone secretion of spontaneous pituitary tumours in the rat.
Prysor-Jones RA; Jenkins JS
J Endocrinol; 1981 Mar; 88(3):463-9. PubMed ID: 7217831
[TBL] [Abstract][Full Text] [Related]
14. Effect of treatment with bromocriptine on the size and activity of prolactin producing pituitary tumours.
Sobrinho LG; Nunes MC; Calhaz-Jorge C; Maurício JC; Santos MA
Acta Endocrinol (Copenh); 1981 Jan; 96(1):24-9. PubMed ID: 7456982
[TBL] [Abstract][Full Text] [Related]
15. Pituitary function in prolactinoma. Effect of surgery and postoperative bromocriptine therapy.
Pelkonen R; Grahne B; Hirvonen E; Karonen SL; Salmi J; Tikkanen M; Valtonen S
Clin Endocrinol (Oxf); 1981 Apr; 14(4):335-48. PubMed ID: 7261416
[TBL] [Abstract][Full Text] [Related]
16. Bromocriptine in management of large pituitary tumours.
Wass JA; Williams J; Charlesworth M; Kingsley DP; Halliday AM; Doniach I; Rees LH; McDonald WI; Besser GM
Br Med J (Clin Res Ed); 1982 Jun; 284(6333):1908-11. PubMed ID: 6805756
[TBL] [Abstract][Full Text] [Related]
17. Hyperprolactinaemia and impotence.
Franks S; Jacobs HS; Martin N; Nabarro JD
Clin Endocrinol (Oxf); 1978 Apr; 8(4):277-87. PubMed ID: 647983
[TBL] [Abstract][Full Text] [Related]
18. Conservative management of pituitary prolactinomas; evidence for bromocriptine-induced regression.
Hancock KW; Scott JS; Lamb JT; Gibson RM; Chapman C
Br J Obstet Gynaecol; 1980 Jun; 87(6):523-9. PubMed ID: 7397087
[TBL] [Abstract][Full Text] [Related]
19. Withdrawal of bromocriptine after long-term therapy for macroprolactinomas; effect on plasma prolactin and tumour size.
van 't Verlaat JW; Croughs RJ
Clin Endocrinol (Oxf); 1991 Mar; 34(3):175-8. PubMed ID: 2036725
[TBL] [Abstract][Full Text] [Related]
20. Bromocriptine treatment of seven women with primary amenorrhoea and prolactin-secreting pituitary tumours.
Bergh T; Nillius SJ; Wide L
Clin Endocrinol (Oxf); 1979 Feb; 10(2):145-54. PubMed ID: 570900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
